Bleeding risk with rivaroxaban compared with vitamin K antagonists in patients aged 80 years or older with atrial fibrillation

cemka > Publications > 2020 > Bleeding risk with rivaroxaban compared with vitamin K antagonists in patients aged 80 years or older with atrial fibrillation
Bleeding risk with rivaroxaban compared with vitamin K antagonists in patients aged 80 years or older with atrial fibrillation
Bleeding risk with rivaroxaban compared with vitamin K antagonists in patients aged 80 years or older with atrial fibrillation

Bleeding risk with rivaroxaban compared with vitamin K antagonists in patients aged 80 years or older with atrial fibrillation

HANON O, VIDAL JS, PISICA-DONOSE G, ORVOËN G, DAVID JP, CHAUSSADE E, CAILLARD L, DE JONG LW, BOULLOCHE N, VINSONNEAU U, BOUEE S, KROLAK-SALMON P, FAUCHIER L, JOUANNY P, SACCO G, BELLARBRE F, BELMIN J, PUISIEUX F, LILAMAND M, PAILLAUD E, BOUREAU AS ; SAFIR STUDY GROUP

Posté par , le 29.03.2021
Classé dans :